本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Seres Therapeutics, Inc.

8.88
-0.0100-0.11%
成交量:3.11萬
成交額:27.40萬
市值:8,033.31萬
市盈率:14.89
高:9.18
開:8.89
低:8.53
收:8.89
52周最高:29.98
52周最低:6.53
股本:904.65萬
流通股本:646.05萬
量比:0.45
換手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):0.5963
每股收益(LYR):0.0175
淨資產收益率:15.95%
總資產收益率:-40.12%
市淨率:1.84
市盈率(LYR):507.34

資料載入中...

公司資料

公司名字:
Seres Therapeutics, Inc.
交易所:
NASDAQ
成立時間:
2010
員工人數:
103
公司地址:
101 Cambridgepark Drive,Cambridge,Massachusetts,United States
郵編:
02140
電話:
傳真:
- -
簡介:
Seres Therapeutics, Inc.於2010年10月根據特拉華州法律註冊成立。該公司是一家商業階段的微生物組療法公司,專註於一類新型生物藥物的開發和商業化,這些藥物旨在通過調節微生物組來治療疾病,通過將被破壞的微生物組的功能修復到非疾病狀態來恢復健康。該公司還在設計微生物組療法,這些療法經過優化,可以去定植病原體並調節宿主功能,以減少和預防感染並誘導免疫耐受。

董事

名稱
職位
Stephen Berenson
Chairman of the Board
Claire M. Fraser
Independent Director
Dennis A. Ausiello
Independent Director
Kurt C. Graves
Independent Director
Paul R. Biondi
Independent Director
Richard N. Kender
Independent Director
Willard H. Dere
Independent Director
Eric D. Shaff
Director
Hans Juergen Woerle
Director

股東

名稱
職位
Marella Thorell
Executive Vice President and Chief Financial Officer,Co-Chief Executive Officer and Co-President
Thomas J. DesRosier
Executive Vice President and Chief Legal Officer,Co-Chief Executive Officer and Co-President
Matthew Henn
Executive Vice President and Chief Scientific Officer
Teresa L. Young
Executive Vice President, Chief Commercial Officer and Chief Strategy Officer